Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Clinical trial NCT06915025 · RECRUITING

Trial details

NCT number: NCT06915025
Sponsor: Imunon
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2025-07-09
Primary completion: 2032-10-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.